By yourNEWS Media Newsroom
WOONSOCKET, R.I. — CVS Health announced Wednesday, Nov. 4, that it will separate its nationwide pharmacy chain from its health insurance and pharmacy benefits operations, reversing years of consolidation that transformed the company into one of America’s largest integrated health care corporations.
The restructuring will create two independent, publicly traded companies: CVS Pharmacy, which will operate approximately 9,000 retail drugstores and related consumer health services, and CVS Health, which will retain Aetna insurance, CVS Caremark and several other health care businesses.
According to the company’s official announcement, the separation is expected to be completed during the first half of 2028, subject to final board approval, regulatory filings and other customary conditions.
The decision follows a comprehensive strategic review by CVS Health’s board of directors and represents a major change in the company’s business model, which has increasingly combined retail pharmacy services, health insurance, prescription drug management and direct medical care.
CVS Chairman and CEO David Joyner will lead the health care services company, which will retain the CVS Health name on an interim basis. Prem Shah, currently group president of CVS Health, will become CEO of the independent CVS Pharmacy business.
The remaining CVS Health company will include Aetna, one of the nation’s largest health insurers; CVS Caremark, a major pharmacy benefit manager; CVS Specialty, which distributes medications for complex medical conditions; Oak Street Health, which operates primary care clinics; and Signify Health, which provides home-based health services.
CVS Pharmacy will operate the company’s retail and mail-order pharmacies, MinuteClinic locations, virtual care services and Health100, a technology platform designed to help consumers manage their health care needs.
In a statement, Joyner said the planned breakup follows two years of efforts to improve the company’s financial performance and strengthen its operations.
“Our history is defined by proactively evolving to stay ahead of what’s next in healthcare, and in today’s environment, that means delivering more affordability, greater access, and a simpler experience,” Joyner said.
“Over the last two years, we have made meaningful progress: we built a world-class leadership team, strengthened our financials, revitalized operations across the enterprise, and drove total shareholder return. From a position of strength, and a focus on the long term, we plan to create two focused companies to improve consumer engagement, affordability, and care coordination.”
The decision comes amid growing scrutiny of large health care corporations that operate multiple businesses within the same industry, particularly companies that own both pharmacies and pharmacy benefit managers.
Pharmacy benefit managers negotiate prescription drug prices and rebates on behalf of health insurers and employers. Their business practices have attracted bipartisan criticism over concerns about drug pricing, reimbursement arrangements and potential conflicts of interest.
According to Reuters, the separation will dismantle a corporate structure that CVS spent decades developing through acquisitions, including its approximately $70 billion purchase of Aetna in 2018.
That acquisition was intended to combine insurance coverage, prescription drug benefits and retail health care services under one corporate organization. CVS executives argued at the time that the arrangement would improve coordination among providers and reduce costs.
The newly announced restructuring will separate much of that integrated business model, allowing the pharmacy chain and health care services company to pursue independent financial and operational strategies.
The decision also comes as CVS confronts financial pressures in both the insurance and retail pharmacy markets.
Aetna has experienced challenges involving rising medical expenses, particularly among patients enrolled in government-supported insurance programs. Meanwhile, traditional pharmacies have faced competition from online prescription services, declining store traffic and pressure on reimbursement rates.
The company’s third-quarter financial filing with the Securities and Exchange Commission confirmed the planned separation and identified it as a significant subsequent event affecting the business.
CVS reported approximately $108.4 billion in third-quarter revenue and $2.2 billion in profit, according to Fierce Healthcare. The results accompanied the restructuring announcement, which was also discussed during the company’s quarterly earnings conference call.
Under the plan, CVS shareholders will receive ownership interests in both companies when the separation is completed. CVS intends to structure the transaction so that it is tax-free to the corporation and its shareholders for U.S. federal income tax purposes.
The company expects both businesses to maintain investment-grade credit ratings, strong cash flow and the financial capacity to invest in future operations while paying dividends.
Additional leadership appointments and board memberships will be announced as the restructuring progresses.
CVS executives said each business will gain greater flexibility to make investment decisions, respond to regulatory developments and pursue partnerships suited to its operations.
For CVS Pharmacy, the strategy includes expanding services provided by the company’s nearly 30,000 pharmacists and developing relationships with insurers, manufacturers and other health care organizations.
The company also intends to continue developing Health100, which uses artificial intelligence and related technology to help consumers access and navigate health services.
Both companies are expected to use the technology as part of broader efforts to improve customer experiences and reduce administrative complexity.
For the health care services business, CVS plans to preserve coordination among Aetna, Caremark, specialty pharmacy operations and medical care providers while pursuing opportunities to reduce costs and improve patient outcomes.
The company emphasized that the restructuring should not interrupt existing services for customers, patients or insurance members.
Prescription medications, pharmacy services, insurance coverage and other health care programs will continue operating during the transition, according to CVS.
The separation will require additional corporate filings, including a Form 10 registration statement with the Securities and Exchange Commission. It also remains subject to final approval from the company’s board and confirmation of the intended federal tax treatment.
Until those conditions are satisfied, CVS Health will continue operating as a single corporation.
The breakup represents a significant shift in the U.S. health care industry, where large corporations have increasingly sought to combine insurance, pharmacy benefits and direct medical services.
As The Wall Street Journal reported, the decision reverses the business strategy behind CVS’s Aetna acquisition while creating two companies with distinct financial priorities and management structures.
For consumers, the immediate impact is expected to be limited, with CVS pharmacies, MinuteClinics and Aetna insurance services continuing to operate during the separation process.
The longer-term effects on prescription drug pricing, insurance premiums, pharmacy operations and shareholder returns will depend on how the companies operate independently after the transaction is completed.
CVS expects to finalize the restructuring by the first half of 2028, ending the current corporate arrangement that combines one of the nation’s largest pharmacy chains with major insurance, prescription benefits and medical care businesses.
Original article
Comments